John Grumitt

John Grumitt has extensive work experience in various roles across different companies.

Their most recent role is as an Advisor to the Board and Interim CEO at Future Care Capital, where they provide guidance on scaling up work and creating a replicable framework for the adoption of mental health technologies.

Prior to that, they served as a Medical Liaison Advisor at Tetris Pharma Limited, supporting the CEO and SMT in establishing relationships and facilitating product launches across Europe.

John also worked in International Business Development at Myndlift, a company providing digital remote access to neurofeedback for treating ADHD and anxiety.

In addition, John Grumitt has held leadership positions such as Chair at iDEAL Diabetes, Trustee (NED) and Chair of the Finance Committee at C3 Collaborating for Health, and Vice President Ambassador and Vice Chair at Diabetes UK.

John has also been involved in consulting and corporate transactions as the Chief Executive of John Grumitt Consulting.

Furthermore, they have served as Chair and Strategic Advisor at Hilldon Health, Chair at IVFbabble.com, and Strategic Advisor and Founder and Chief Executive at Changing Health.

Throughout their career, John Grumitt has focused on improving health and care, particularly in the areas of diabetes, non-communicable diseases, and lifestyle management.

John Grumitt has a BA in Economics from the University of Manchester, which they obtained from 1984 to 1987. John is a Chartered Accountant and a Member and Fellow of the ICAEW (Institute of Chartered Accountants of England and Wales), which they obtained in 1990. John also completed an Executive Development Programme in Post MBA Management Development at The Wharton School in 1998.